Although aberrant high CDK activity is clearly associated with NB (Molenaar et al., 2009, , 2008), one of the strongest markers of poor prognosis for individuals with NB is MYCN amplification (Brodeur, 2003). The gene discussed is MYCN; the disease is neuroblastoma.